Generic Drug Companies Fund FDA User-Fee Program


A tentative deal between the generic drug industry and the federal government will require generic drugmakers to pay annual fees in order to increase FDA inspection of foreign-based manufacturing plants. The proposed deal, which totals approximately $299 million, is similar to the ones that currently exist for companies who produce brand-name drugs and medical devices. [...]